Neuralink Receives FDA Approval for In-Human Clinical Trials
Elon Musk's neurotechnology company Neuralink received approval from the Food and Drug Administration (FDA) to perform in-human clinical trials.
The announcement(Opens in a new window) was made via the Neuralink Twitter account, stating "This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people."
Neuralink is developing an implantable brain-computer interface and has been testing its devices using live animals. Now it seems the company can move on to testing on human subjects, but Neuralink's tweet makes it clear they aren't ready to recruit people for the clinical trial just yet. If you want "in," then stay tuned for Neuralink to "announce more information on this soon!"
The company may be setting impossibly high expectations, but if successful, Neuralink hopes to create a brain interface that can "restore autonomy to those with unmet medical needs today and unlock human potential tomorrow." However, the company was placed under investigation earlier this year for alleged mishandling of monkey brain implants. Clinical trials involving humans will only increase the scrutiny of its practices.
Sign up for What's New Now to get our top stories delivered to your inbox every morning.
This newsletter may contain advertising, deals, or affiliate links. Subscribing to a newsletter indicates your consent to our Terms of Use and Privacy Policy. You may unsubscribe from the newsletters at any time.
Your subscription has been confirmed. Keep an eye on your inbox!
Read more on pcmag.com
